NCT07089979Completed
Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes
A Randomized Study of the Glunovo Real-Time Continuous Glucose Monitoring (CGM) Effectiveness on Metabolic Control in Patients With Type 2 Diabetes (T2D)
Source: ClinicalTrials.gov · Last updated 29 Jul 2025
Brief summary (registry, in English)
The study aims to evaluate the effectiveness of the novel Real-Time Continuous Glucose Monitoring (RT-CGM) system "Glunovo" in improving glycemic control and patient-reported outcomes in individuals with poorly controlled Type 2 Diabetes (T2D).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 260 (actual)
- First submitted
- 9 Apr 2025
- Start date
- 1 Jan 2024
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- University of Milan
- Diseases
- Type 2 diabetes
- NCT number
- NCT07089979
What you commit to
- Study type: Interventional
- Participants enrolled: 260
- From 1 Jan 2024 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Pregnancy HbA1c \> 11% or \< 7.5% Diagnosis of Type 1 Diabetes, Latent Autoimmune Diabetes in Adults (LADA), Maturity Onset Diabetes of the Young (MODY), or other forms of hyperglycemia
Who the study is looking for
- Diagnosis of Type 2 Diabetes (T2D) Age above 18 years Glycated Hemoglobin (HbA1c) between 7.5% and 11% On basal-bolus insulin, basal-oral combination therapy, or non-insulin antidiabetic therapy
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ASST Sacco Fatebenefratelli Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
Related publications
- A Randomized Study of the Glunovo Real-time CGM Effectiveness in Individuals With Poorly Controlled Type 2 Diabetes.J Endocr Soc · 2026 · PMID 41551204
This page is information, not medical advice. Discuss any trial with your doctor.